3M Acquires Acelity (and KCI) from Apax-led Consortium for $6.725B

KKR to Acquire Healthium MedTech from Apax Funds

May 6, 2024

Medical Devices

KKR (through funds it manages) has signed definitive agreements to acquire a controlling interest in Healthium MedTech Ltd. from funds advised by Apax Partners. The transaction, expected to close in Q3 2024 subject to regulatory approvals, will support Healthium's next phase of global growth and product/market expansion.

KCC Corporation to Fully Acquire Momentive Performance Materials Group

March 28, 2024

Manufacturing

KCC Corporation, the Seoul-based chemicals manufacturer, has entered into an agreement to fully acquire Momentive Performance Materials Group, consolidating ownership and resulting in the exit of minority shareholder SJL Partners LLC. The transaction, which remains subject to customary closing conditions, brings Momentive (a global silicones and specialty materials manufacturer headquartered in Niskayuna, New York) under 100% KCC ownership to support expanded collaboration and capability growth.

Permira Acquires Majority Stake in Acuity Knowledge Partners from Equistone

January 27, 2023

Professional Services

Funds advised by Permira have acquired a majority stake in Acuity Knowledge Partners from Equistone Partners Europe; Equistone will reinvest as a minority shareholder and Acuity's management remains significantly invested. Headquartered in London, Acuity is a provider of research, analytics and business intelligence to financial services firms worldwide; Permira plans to support further investment in teams, services and technology to drive growth and geographic expansion. The deal is subject to customary regulatory approvals and was expected to close in Q2 2023; financial terms were not disclosed.

Merck to Acquire Acceleron Pharma Inc for $11.5B

September 30, 2021

Biotechnology

Merck (through a subsidiary) entered into a definitive agreement to acquire Acceleron Pharma Inc for $180 per share in cash, for an approximate total equity value of $11.5 billion. The transaction will be completed via a tender offer followed by a merger, and is expected to close in the fourth quarter of 2021, subject to conditions including regulatory approvals and tender of at least a majority of outstanding shares.

Altaris Capital Partners Acquires Kindeva Drug Delivery from 3M

May 1, 2020

Medical Devices

Altaris Capital Partners has acquired Kindeva Drug Delivery L.P. (formerly 3M Drug Delivery Systems) from 3M Company for $650 million in a corporate carve-out transaction. Monroe Capital provided financing and an equity co-investment to support the deal, and 3M will retain a minority interest alongside Altaris as Kindeva operates independently to pursue growth and capital investments.

3M Acquires M*Modal's Technology Business

December 19, 2018

Healthcare Services

3M has entered into a definitive agreement to acquire the technology business of M*Modal for an enterprise value of $1.0 billion, expanding 3M Health Information Systems' capabilities in conversational AI and clinical documentation. The acquired business, based in Pittsburgh, Pennsylvania, generates approximately $200 million in annual revenue and about 750 employees are expected to join 3M; M*Modal will retain its transcription, scribing and coding services business.